8-K
filed June 3, 2026, 4:25 PM ET
ticker SRTA
CIK 0001779128
other
confidence high
sentiment neutral
materiality 0.15
Strata Critical Medical stockholders elect directors Heyburn and Lauck, ratify Deloitte, approve say-on-pay
Strata Critical Medical, Inc.
- William A. Heyburn re-elected with 46,050,902 for, 505,421 withhold, 12,687,496 broker non-votes.
- Andrew Lauck re-elected with 39,525,159 for, 7,031,164 withhold, 12,687,496 broker non-votes.
- Ratification of Deloitte & Touche as auditor: 58,946,832 for, 65,815 against, 231,172 abstain.
- Advisory say-on-pay approved: 38,497,962 for, 8,022,682 against, 35,679 abstain, 12,687,496 broker non-votes.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Strata Critical Medical, Inc. shareholders approved Election of two Class II directors to hold office until the 2029 annual meeting at the 2026-05-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
For Withhold Broker Non-Votes William A. Heyburn 46,050,902 505,421 12,687,496 Andrew Lauck 39,525,159 7,031,164 12,687,496
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Strata Critical Medical, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2026-05-28 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
For Against Abstain Broker Non-Votes 38,497,962 8,022,682 35,679 12,687,496
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Strata Critical Medical, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
For Against Abstain 58,946,832 65,815 231,172
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.